K D Rosenman1, M Moore-Fuller, M J Reilly. 1. Department of Medicine, Michigan State University, East Lansing, 48824-1316, USA. Rosenman@pilot.msu.edu
Abstract
AIM: To determine the prevalence of kidney disease in a cohort of individuals with silicosis. METHODS: Review of medical records and questionnaires from patients reported to a state surveillance system for silicosis. Reporting of individuals with silicosis is required by state law. All individuals with silicosis reported as required by law to the State of Michigan. Individuals included in this article were reported from 1987 to 1995. Cases were reported by hospitals, physicians, the state workers' compensation bureau, or from death certificates. Only individuals who met the criteria for silicosis developed by the National Institute for Occupational Safety and Health (NIOSH) were included. RESULTS: Medical records were reviewed of 583 individuals with confirmed silicosis. This was mainly a population of elderly men. Ten percent of the 583 silicotics were found to have some mention of chronic kidney disease, and 33% of the 283 silicotics who we had laboratory tests on had a serum creatinine level >1.5 mg/dl. An association between kidney disease and age and between kidney disease and race was found among this cohort of 583 silicotics. Individuals with silicosis were more likely to have a serum creatinine level >1.5 mg/dl than age- and race-matched controls. However, no relationship between duration of exposure to silica or profusion of scarring on chest X-ray and prevalence of kidney disease or elevated creatinine levels was found. CONCLUSIONS: This study confirms previous case reports and epidemiologic studies of end-stage renal disease that found an association between kidney disease and exposure to silica. The epidemiologic data are conflicting on the mechanism by which silica causes kidney disease and are compatible with silica being able to cause kidney disease by both an autoimmune and direct nephrotoxic effect. Chronic kidney disease should be considered as a complication of silicosis. Copyright 2000 S. Karger AG, Basel
AIM: To determine the prevalence of kidney disease in a cohort of individuals with silicosis. METHODS: Review of medical records and questionnaires from patients reported to a state surveillance system for silicosis. Reporting of individuals with silicosis is required by state law. All individuals with silicosis reported as required by law to the State of Michigan. Individuals included in this article were reported from 1987 to 1995. Cases were reported by hospitals, physicians, the state workers' compensation bureau, or from death certificates. Only individuals who met the criteria for silicosis developed by the National Institute for Occupational Safety and Health (NIOSH) were included. RESULTS: Medical records were reviewed of 583 individuals with confirmed silicosis. This was mainly a population of elderly men. Ten percent of the 583 silicotics were found to have some mention of chronic kidney disease, and 33% of the 283 silicotics who we had laboratory tests on had a serum creatinine level >1.5 mg/dl. An association between kidney disease and age and between kidney disease and race was found among this cohort of 583 silicotics. Individuals with silicosis were more likely to have a serum creatinine level >1.5 mg/dl than age- and race-matched controls. However, no relationship between duration of exposure to silica or profusion of scarring on chest X-ray and prevalence of kidney disease or elevated creatinine levels was found. CONCLUSIONS: This study confirms previous case reports and epidemiologic studies of end-stage renal disease that found an association between kidney disease and exposure to silica. The epidemiologic data are conflicting on the mechanism by which silica causes kidney disease and are compatible with silica being able to cause kidney disease by both an autoimmune and direct nephrotoxic effect. Chronic kidney disease should be considered as a complication of silicosis. Copyright 2000 S. Karger AG, Basel
Authors: Suma Vupputuri; Christine G Parks; Leena A Nylander-French; Ashli Owen-Smith; Susan L Hogan; Dale P Sandler Journal: Ren Fail Date: 2011-10-27 Impact factor: 2.606
Authors: Susan L Hogan; Glinda S Cooper; David A Savitz; Leena A Nylander-French; Christine G Parks; Hyunsook Chin; Caroline E Jennette; Sofia Lionaki; J Charles Jennette; Ronald J Falk Journal: Clin J Am Soc Nephrol Date: 2007-02-07 Impact factor: 8.237
Authors: Hyeon Woo Lee; Yong Jun Choi; Se Won Oh; Hye Kyeong Park; Kum Hyun Han; Han Seong Kim; Sang Youb Han Journal: Case Rep Nephrol Date: 2014-12-10
Authors: Alexander Lenander-Ramirez; Ing-Liss Bryngelsson; Per Vihlborg; Håkan Westberg; Lena Andersson Journal: J Occup Environ Med Date: 2022-03-11 Impact factor: 2.306